Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

649 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 102
Recruiting: 49
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (104)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03481868	EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors(EPIK)	unknown	N/A	160	University Hospital, Clermont-FerrandOTHER	1	Apr 9, 2024	clinicaltrials
NCT04663100	Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence	unknown	N/A	30	University of TennesseeOTHER	1	Dec 4, 2023	clinicaltrials